New developments in the treatment of HER2-positive breast cancer

Rita NahtaDepartments of Pharmacology and Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USAAbstract: Approximately 20%–30% of metastatic breast cancers show increased expression of the human epidermal growth factor receptor-2 (HER2) tyrosine...

Full description

Saved in:
Bibliographic Details
Main Author: Nahta R
Format: article
Language:EN
Published: Dove Medical Press 2012
Subjects:
Online Access:https://doaj.org/article/69bf0c17c440412fba760e2a1afed307
Tags: Add Tag
No Tags, Be the first to tag this record!